STING1 and diabetes mellitus: At the same time, owing to the contribution of the cGAS–STING pathway in different organs, inhibition of the cGAS–STING pathway-induced inflammatory pathway provides a potential avenue for therapeutic drug development for diabetes and subsequent diabetes-related complications.